Clinical Trial Update: Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating PreveCol as a second-line method for early detection of colorectal cancer and is currently recruiting. The study involve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: ADVANCED MARKER DISCOVERY S.L. | Conditions: Screening for Colon Cancer, Blood Samples | NA | Status: RECRUITING